Viewing nowCombinationMizartan Plus Tablet 80/12.5 mg (Telmisartan, Hydrochlorothiazide)
Telmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
IYUN Pharmaceuticals Co., Ltd.

MFDS item code 201903559 · Approved 2019.05.29 · Insurance code 658604660
Treatment of essential hypertension not controlled with telmisartan alone
This medication is used for the treatment of essential hypertension. It helps to more effectively control blood pressure when added to patients whose blood pressure is not sufficiently controlled by Telmisartan alone. It manages blood pressure safely and effectively, reducing the risk of complications.
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg per day of this medicine. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with hepatic dysfunction. Elderly patients No dose adjustment is necessary.
The safety and efficacy of this medicine have not been established in children under 18 years of age.
This medication can pose a significant risk to the fetus, especially during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with an allergy to the active ingredients or additives, pregnant or nursing women, or patients with severe liver or kidney diseases. Elderly patients, those with elevated potassium levels, or patients with weakened liver function, valvular heart disease, or ischemic heart disease should use this medication cautiously. The Hydrochlorothiazide component may sensitize the skin to sunlight, increasing the risk of skin cancer; therefore, sun exposure should be avoided during use, and the skin should be monitored periodically. This medication lowers blood pressure, and symptoms such as dizziness, hypotension, and fainting may occur. Electrolyte imbalances can occur, making it important to regularly check the levels of potassium, sodium, and other electrolytes through blood tests. Particular caution is essential for patients with impaired kidney function or those who are dehydrated or sodium deficient, as there is a risk of hypotension or kidney failure; improving these conditions before taking the medication is crucial. This medication may interact with other antihypertensives, diuretics, lithium, and non-steroidal anti-inflammatory drugs; it is essential to inform healthcare professionals of any medications being taken. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised, and such activities should be avoided if symptoms are present. Overdose may result in hypotension, electrolyte abnormalities, dehydration, and it is vital to adhere to the recommended dosage; seek immediate medical attention if adverse symptoms occur. This medication is not recommended for use in children under 18 years of age, as its safety and efficacy have not been established.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius (room temperature). Proper storage will help maintain the medication's efficacy and ensure safe use.
White or off-white elongated tablet
30 tablets (10 tablets/Alu-Alu * 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
IYUN Pharmaceuticals Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hanmi Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.